TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34480858

Group type: EXPERIMENTAL
Intervention: Third dose of ChAdOx1 nCoV-19 (given 28-38 weeks after the second dose)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Late second dose of ChAdOx1 nCoV-19 (given 44-45 weeks after the first dose)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Single dose of ChAdOx1 nCoV-19
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Third dose of ChAdOx1 nCoV-19
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Late second dose of ChAdOx1 nCoV-19
Number of subjects: 90
Study: 33262186

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure (SMBP)
Number of subjects: 147
Study: 35724857

Group type: EXPERIMENTAL
Intervention: Low dose (3 mg/kg/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High dose (10 mg/kg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (distilled water)
Number of subjects: 30
Study: 32767145

Group type: EXPERIMENTAL
Intervention: AirSeal® (group A)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Standard CO2 insufflator (group S)
Number of subjects: 198
Study: 32650818

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (600 mg first dose, then 200 mg twice daily for 7 days, total 3 g)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (equivalent number of capsules to Hydroxychloroquine)
Number of subjects: 120
Study: 35583585

Group type: EXPERIMENTAL
Intervention: Joint production pedagogy
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study: 33027166

Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Hemiarthroplasty
Number of subjects: 1441
Study: 33345878

Group type: EXPERIMENTAL
Intervention: Breastfeeding Friend smartphone application
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control smartphone application
Number of subjects: 170
Study: 33111563

Group type: EXPERIMENTAL
Intervention: Supported dynamic lumbar extension with the abdominal drawing‐in maneuver (ADIM) technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control-sitting without exercise
Number of subjects: 30
Study: 35881180

Group type: EXPERIMENTAL
Intervention: Systemic treatment with sorafenib (either alone or combined with locoregional therapies)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 67
Study: 33452438

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 32700596

Group type: EXPERIMENTAL
Intervention: 8 mm ultra-thin wall (UTW) staked needle syringe
Number of subjects: 0

Group type: COMPARATOR
Intervention: 12.7 mm special-thin wall (STW) staked needle syringe
Number of subjects: 0
Study: 35649613

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus personal protective equipment
Number of subjects: 416

Group type: COMPARATOR
Intervention: Personal protective equipment alone
Number of subjects: 416
Study: 32078837

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Psychoeducation (PE)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 52
Study: 35951124

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (ERL) set at energy level of 100 mJ/pulse, frequency of 10 Hz, pulse duration of 100 µs, irradiated by three passages
Number of subjects: 23

Group type: COMPARATOR
Intervention: Mechanical debridement using an ultrasonic scaler
Number of subjects: 23
Study: 33283994

Group type: EXPERIMENTAL
Intervention: Severe SCFE
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Epiphyseal rotation
Number of subjects: 51
Study: 34937222

Group type: EXPERIMENTAL
Intervention: SRK/T
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Holladay 2
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Barrett Universal II
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: SRK II
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Hoffer Q
Number of subjects: 164
Study: 32790575

Group type: EXPERIMENTAL
Intervention: Dynamic hamstring stretching with strengthening exercises
Number of subjects: 46

Group type: COMPARATOR
Intervention: Static hamstring stretching with strengthening exercises
Number of subjects: 46
Study: 33314461

Group type: EXPERIMENTAL
Intervention: Oil pulling (sunflower oil)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Mineral water
Number of subjects: 26
Study: 33789555

Group type: EXPERIMENTAL
Intervention: Probiotic treatment (Limosilactobacillus fermentum LF16, Lacticaseibacillus rhamnosus LR06, Lactiplantibacillus plantarum LP01, Bifidobacterium longum 04)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo treatment (maltodextrin)
Number of subjects: 33
Study: 35271448

Group type: EXPERIMENTAL
Intervention: VIRTUE (immersive virtual reality application)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32474982

Group type: EXPERIMENTAL
Intervention: E2 (WB50 extended in a 2:1 ratio with milk-based extender)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (pure raw semen)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: E1 (WB50 extended in a 1:1 ratio with milk-based extender)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: WB50 (50% whole blood added into semen)
Number of subjects: 15
Study: 34283851

Group type: EXPERIMENTAL
Intervention: Breakthrough series collaborative intervention including data collection, learning events, Plan-Study-Do-Act cycles, and teleconferences every 6 weeks.
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Breakthrough series collaborative intervention
Number of subjects: 586
Study: 32506922

Group type: EXPERIMENTAL
Intervention: mHealth intervention (electronic medication tray and mHealth app)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 80
Study: 36163020

Group type: EXPERIMENTAL
Intervention: Camostat mesilate (600 mg qid for up to 14 days)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 34174325

Group type: EXPERIMENTAL
Intervention: Fragmented sleep
Number of subjects: 9

Group type: COMPARATOR
Intervention: Uninterrupted sleep
Number of subjects: 9
Study: 36194970

Group type: EXPERIMENTAL
Intervention: Teaching strategy combining the 5E learning model and self‐efficacy
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional teaching methods
Number of subjects: 58
Study: 33611132

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Relaxation Training (RT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) or Relaxation Training (RT)
Number of subjects: 51
Study: 36054737

Group type: EXPERIMENTAL
Intervention: Mealtime ultra rapid lispro (URLi)
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Postmeal ultra rapid lispro (URLi)
Number of subjects: 716

Group type: COMPARATOR
Intervention: Lispro
Number of subjects: 716
Study: 33479721

Group type: EXPERIMENTAL
Intervention: 80-mg ixekizumab (IXE) every 2 weeks
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: 80-mg ixekizumab (IXE) every 4 weeks
Number of subjects: 363

Group type: COMPARATOR
Intervention: 80-mg ixekizumab (IXE)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 363
Study: 36169991

Group type: EXPERIMENTAL
Intervention: Calm app intervention
Number of subjects: 1029

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 1029
Study: 32840319

Group type: EXPERIMENTAL
Intervention: Expander with differential opening (EDO)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fan-type expander (FE)
Number of subjects: 48
Study: 33585991

Group type: EXPERIMENTAL
Intervention: Stent placement combined with intra‐RFA and HAIC
Number of subjects: 135

Group type: COMPARATOR
Intervention: Stent placement only (Control)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Adverse events related to biliary tract operation
Number of subjects: 135
Study: 36221346

Group type: EXPERIMENTAL
Intervention: T2 (T = 36 ± 1°C)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: T3 (T = 40 ± 1°C)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: T4 (T = 48 ± 1°C)
Number of subjects: 144

Group type: COMPARATOR
Intervention: T1 (T = 24 ± 1°C)
Number of subjects: 144
Study: 33704030

Group type: EXPERIMENTAL
Intervention: Free-range reindeer (FR)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Commercial beef (CB)
Number of subjects: 7
Study: 32041671

Group type: EXPERIMENTAL
Intervention: Edible ectomycorrhizal fungi from the Yangambi Biosphere reserve and Yoko forest reserve
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Mixed forest stands
Number of subjects: 160

Group type: COMPARATOR
Intervention: Monodominant forests
Number of subjects: 160
Study: 34240455

Group type: EXPERIMENTAL
Intervention: TAK-071 40-80 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TAK-071 120-160 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TAK-071 (high doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TAK-071 with donepezil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TAK-071 (overall)
Number of subjects: 0
Study: 33017484

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Daily plasma exchange and oral prednisone
Number of subjects: 1
Study: 34794178

Group type: EXPERIMENTAL
Intervention: COVID-19 vaccination among REPRIEVE participants
Number of subjects: 6952

Group type: EXPERIMENTAL
Intervention: Factors associated with COVID-19 vaccination
Number of subjects: 6952
Study: 32937046

Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo (ambient air from a sham concentrator)
Number of subjects: 243
Study: 36300280

Group type: EXPERIMENTAL
Intervention: PEG‐rhG‐CSF
Number of subjects: 40

Group type: COMPARATOR
Intervention: rhG‐CSF
Number of subjects: 40
Study: 33905134

Group type: EXPERIMENTAL
Intervention: EVE (leuprorelin + LET + EVE)
Number of subjects: 137

Group type: COMPARATOR
Intervention: LET (leuprorelin + LET)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: EVE + LET with ovarian suppression
Number of subjects: 137
Study: 32990214

Group type: EXPERIMENTAL
Intervention: HUG116 tablet; tenofovir disoproxil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Viread tablet; tenofovir disoproxil fumarate
Number of subjects: 50
Study: 35357396

Group type: EXPERIMENTAL
Intervention: Carotuximab plus pazopanib
Number of subjects: 123

Group type: COMPARATOR
Intervention: Pazopanib alone
Number of subjects: 123
Study: 36057498

Group type: EXPERIMENTAL
Intervention: Forced-air warming (38°C)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Warmed intravenous fluid (37°C)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 32762590

Group type: EXPERIMENTAL
Intervention: High-intensity HVC communication skills curriculum
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard HVC communication SP encounter
Number of subjects: 30
Study: 36164121

Group type: EXPERIMENTAL
Intervention: Pirtobrutinib monotherapy
Number of subjects: 500

Group type: COMPARATOR
Intervention: Investigator's choice of covalent BTK inhibitor monotherapy (ibrutinib, acalabrutinib, or zanubrutinib)
Number of subjects: 500
Study: 33999521

Group type: EXPERIMENTAL
Intervention: Semen swim-up
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pellet swim-up
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Density gradient
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Density gradient followed by semen swim-up
Number of subjects: 60
Study: 32628620

Group type: EXPERIMENTAL
Intervention: Subvastus (S) exposure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medial parapatellar (MP) exposure
Number of subjects: 60
Study: 35670067

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 5988

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5988
Study: 35334973

Group type: EXPERIMENTAL
Intervention: Novel fermented miso-type sauce enhanced with 50% carotenoid-rich fruit peel extract
Number of subjects: 14

Group type: COMPARATOR
Intervention: Rice meal with legume-based sauce (control)
Number of subjects: 14
Study: 32028253

Group type: COMPARATOR
Intervention: Brief Advice (BA)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: BMI + B (with telephone booster)
Number of subjects: 395
Study: 37755683

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program including supervised walking, squat, balance, and inspiratory muscle training (IMT) with two daily sessions.
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (CG) with no specific intervention mentioned.
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program including IMT.
Number of subjects: 174
Study: 34529735

Group type: EXPERIMENTAL
Intervention: Individual feedback letters reporting measured physical activity (PA) and physical inactivity (PI)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group (no feedback letters)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 166
Study: 32898690

Group type: EXPERIMENTAL
Intervention: Nomogram developed from clinical data using univariate and multivariate Cox regression analyses.
Number of subjects: 98640
Study: 36157826

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP)
Number of subjects: 102
Study: 32331476

Group type: EXPERIMENTAL
Intervention: Meal intake after resistance exercise (Post)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Meal intake before resistance exercise (Pre)
Number of subjects: 8

Group type: COMPARATOR
Intervention: RE without meal intake (No)
Number of subjects: 8
Study: 35083807

Group type: EXPERIMENTAL
Intervention: Predictive physical fitness age information
Number of subjects: 253

Group type: COMPARATOR
Intervention: Control group (no predictive physical fitness age information)
Number of subjects: 253
Study: 32053067

Group type: EXPERIMENTAL
Intervention: Various pharmaceutical agents (gonadotropins, anti‐estrogen agents, aromatase inhibitors)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (implied control)
Number of subjects: 0
Study: 35113160

Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan (T-DXd)
Number of subjects: 1452

Group type: EXPERIMENTAL
Intervention: Pathologist assessment of breast cancer biopsies
Number of subjects: 1452
Study: 32919045

Group type: EXPERIMENTAL
Intervention: Celecoxib 1 hour prior to the procedure and for 3 weeks postoperatively
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 34265312

Group type: EXPERIMENTAL
Intervention: Propranolol (1 mg/kg po QID)
Number of subjects: 40
Study: 33297843

Group type: EXPERIMENTAL
Intervention: Anodal 1 mA tDCS
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 52
Study: 32593228

Group type: EXPERIMENTAL
Intervention: E-learning on smartphones with interactive learning materials including videos of dental treatments
Number of subjects: 293

Group type: COMPARATOR
Intervention: Control group with no learning materials
Number of subjects: 293
Study: 33908131

Group type: EXPERIMENTAL
Intervention: Alcohol administration in humans
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol administration in Ghsr knockout and wild-type rats
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcohol administration versus calorically equivalent non-alcoholic sucrose solution in rats
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol administration on ghrelin secretion from gastric mucosa cells ex vivo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GOAT enzymatic activity in vitro
Number of subjects: 0
Study: 34490583

Group type: EXPERIMENTAL
Intervention: Total cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multivariable MR analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reverse MR analysis
Number of subjects: 0
Study: 35932720

Group type: EXPERIMENTAL
Intervention: Insulin glargine (10 UI once a day for 7 days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Saline solution (control group, once a day for 7 days)
Number of subjects: 36
Study: 33011095

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise-training program (2 sessions/day for 5 to 7 consecutive days)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise-training program
Number of subjects: 185

Group type: COMPARATOR
Intervention: Usual-care group (habitual hospital care)
Number of subjects: 185
Study: 34625211

Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG) implemented by teachers in intervention schools during the 2-year main trial period (Time 1 to Time 3)
Number of subjects: 3084

Group type: COMPARATOR
Intervention: Usual practice by teachers in control schools
Number of subjects: 3084
Study: 35543543

Group type: EXPERIMENTAL
Intervention: 2% CHX
Number of subjects: 61

Group type: COMPARATOR
Intervention: 4% CHX
Number of subjects: 61
Study: 33044837

Group type: EXPERIMENTAL
Intervention: Video-based nursing education
Number of subjects: 128
Study: 35306386

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Exercise and NMES (EX + NMES)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Functional capacity
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Lung function
Number of subjects: 27
Study: 33843296

Group type: EXPERIMENTAL
Intervention: Brief intervention (examination and advice by a rheumatologist and a physiotherapist)
Number of subjects: 476

Group type: COMPARATOR
Intervention: Multidisciplinary intervention (brief intervention plus coaching by a case manager)
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 476

Group type: COMPARATOR
Intervention: Multidisciplinary intervention
Number of subjects: 476
Study: 33218847

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Higher self-efficacy
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Healthier eating intentions
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Healthier household food patterns
Number of subjects: 580
Study: 32643076

Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics
Number of subjects: 5

Group type: COMPARATOR
Intervention: No antibiotics/placebo
Number of subjects: 5
Study: 35211743

Group type: EXPERIMENTAL
Intervention: Roluperidone 64 mg/day
Number of subjects: 513

Group type: COMPARATOR
Intervention: Roluperidone 32 mg/day
Number of subjects: 513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513
Study: 35662406

Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg bodyweight orally three times per week)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 35385369

Group type: EXPERIMENTAL
Intervention: COPD-CPHS screening questionnaire (cutoff point ≥16)
Number of subjects: 33664

Group type: EXPERIMENTAL
Intervention: Development set AUC
Number of subjects: 33664

Group type: EXPERIMENTAL
Intervention: Validation set AUC
Number of subjects: 33664
Study: 33270298

Group type: EXPERIMENTAL
Intervention: Non-PV trigger-targeted ablation (Group 2)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Non-PV trigger-targeted ablation (Group 1)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-PV triggers still inducible after CA (Group 3)
Number of subjects: 300
Study: 32631129

Group type: EXPERIMENTAL
Intervention: Esketamine
Number of subjects: 0
Study: 34697034

Group type: EXPERIMENTAL
Intervention: A. soehngenii infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 12
Study: 33138708

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group (without psychiatric illness)
Number of subjects: 390
Study: 37656449

Group type: EXPERIMENTAL
Intervention: Prophylactic ranibizumab (PR) injections every 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham injections
Number of subjects: 0
Study: 33754371

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 54
Study: 32306247

Group type: EXPERIMENTAL
Intervention: Insulin degludec 200 units/mL
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine 300 units/mL
Number of subjects: 0
Study: 36074760

Group type: EXPERIMENTAL
Intervention: Tighter glycaemic targets (FPG ≤5.0 mmol/L, 1-hour ≤7.4 mmol/L, 2-hour postprandial ≤6.7 mmol/L)
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Tighter glycaemic targets
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Less tight glycaemic targets (FPG <5.5 mmol/L, 1-hour <8.0 mmol/L, 2-hour postprandial <7.0 mmol/L)
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Less tight glycaemic targets
Number of subjects: 1100
Study: 32699911

Group type: EXPERIMENTAL
Intervention: Flaxseed muffins (30 g total, consumed once in the morning)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Flaxseed muffins (10 g per muffin, consumed three times a day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control muffins (0 g flaxseed, consumed three times a day)
Number of subjects: 15
Study: 35193378

Group type: EXPERIMENTAL
Intervention: Ezetimibe
Number of subjects: 20

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 20
Study: 33308907

Group type: EXPERIMENTAL
Intervention: Daily disposable toric contact lenses
Number of subjects: 38
Study: 35664958

Group type: EXPERIMENTAL
Intervention: Khorasan wheat diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control wheat diet
Number of subjects: 20
Study: 33961006

Group type: EXPERIMENTAL
Intervention: Colchicine (0.5-1.0 mg daily)
Number of subjects: 11600